These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34917922)

  • 1. Quantifying the burden of disease in patients with Lennox Gastaut syndrome.
    Spoor JKH; Greco T; Kamp MA; Faini S; Senft C; Dibué M
    Epilepsy Behav Rep; 2021; 16():100508. PubMed ID: 34917922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does response to vagus nerve stimulation for drug-resistant epilepsy differ in patients with and without Lennox-Gastaut syndrome?
    Dibué M; Greco T; Spoor JKH; Senft C; Kamp MA
    Brain Behav; 2023 Aug; 13(8):e3025. PubMed ID: 37386739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of corpus callosotomy following vagus nerve stimulation in children with Lennox-Gastaut syndrome: A multicenter, multinational study.
    Roth J; Bergman L; Weil AG; Brunette-Clement T; Weiner HL; Treiber JM; Shofty B; Cukiert A; Cukiert CM; Tripathi M; Sarat Chandra P; Bollo RJ; Machado HR; Santos MV; Gaillard WD; Oluigbo CO; Ibrahim GM; Jallo GI; Shimony N; O'Neill BR; Budke M; Pérez-Jiménez MÁ; Mangano FT; Iwasaki M; Iijima K; Gonzalez-Martinez J; Kawai K; Ishishita Y; Elbabaa SK; Bello-Espinosa L; Fallah A; Maniquis CAB; Ben-Zvi I; Tisdall M; Panigrahi M; Jayalakshmi S; Blount JP; Dorfmüller G; Bulteau C; Stone SS; Bolton J; Singhal A; Connolly M; Alsowat D; Alotaibi F; Ragheb J; Uliel-Sibony S
    Epilepsia; 2023 Dec; 64(12):3205-3212. PubMed ID: 37823366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndrome.
    Katagiri M; Iida K; Kagawa K; Hashizume A; Ishikawa N; Hanaya R; Arita K; Kurisu K
    Acta Neurochir (Wien); 2016 May; 158(5):1005-12. PubMed ID: 26979179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Vagus Nerve Stimulation in Lennox-Gastaut Syndrome: A Scoping Review.
    Samanta D
    Children (Basel); 2024 Jul; 11(8):. PubMed ID: 39201840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of auto-stimulation-VNS in children with Lennox-Gastaut syndrome.
    Abdelmoity SA; Abdelmoity AA; Riordan SM; Kaufman C; Le Pichon JB; Abdelmoity A
    Seizure; 2021 Mar; 86():168-174. PubMed ID: 33626436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe autonomic nervous system imbalance in Lennox-Gastaut syndrome patients demonstrated by heart rate variability recordings.
    Hödl S; Olbert E; Mahringer C; Carrette E; Meurs A; Gadeyne S; Dauwe I; Goossens L; Raedt R; Boon P; Vonck K
    Epilepsy Res; 2021 Nov; 177():106783. PubMed ID: 34626869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clobazam is efficacious for patients across the spectrum of disease severity of Lennox-Gastaut syndrome: post hoc analyses of clinical trial results by baseline seizure-frequency quartiles and VNS experience.
    Wheless JW; Isojarvi J; Lee D; Drummond R; Benbadis SR
    Epilepsy Behav; 2014 Dec; 41():47-52. PubMed ID: 25282105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagus nerve stimulation in patients with therapy-resistant generalized epilepsy.
    Suller Marti A; Mirsattari SM; MacDougall K; Steven DA; Parrent A; de Ribaupierre S; Andrade A; Diosy D; McLachlan RS; Burneo JG
    Epilepsy Behav; 2020 Oct; 111():107253. PubMed ID: 32615417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vagus nerve stimulation in patients with Lennox-Gastaut syndrome: A meta-analysis.
    Dibué M; Greco T; Spoor JKH; Tahir Z; Specchio N; Hänggi D; Steiger HJ; Kamp MA
    Acta Neurol Scand; 2021 May; 143(5):497-508. PubMed ID: 33188523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Callosotomy vs Vagus Nerve Stimulation in the Treatment of Lennox-Gastaut Syndrome: A Systematic Review With Meta-Analysis.
    Ferreira Soares D; Pires de Aguiar PH
    Neuromodulation; 2023 Apr; 26(3):518-528. PubMed ID: 35989160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world use of the updated refractory epilepsy screening tool for Lennox-Gastaut syndrome.
    Wolf SM; Boyce D; Peña P; Piña-Garza JE; Roland JJ; Thomas B; Zogejani D; McGoldrick PE
    Epilepsia Open; 2024 Aug; 9(4):1277-1286. PubMed ID: 38726917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norwegian population-based study of effectiveness of vagus nerve stimulation in patients with developmental and epileptic encephalopathies.
    Kostov KH; Kostov H; Larsson PG; Henning O; Aaberg KM; Egge A; Peltola J; Lossius MI
    Epilepsia Open; 2024 Apr; 9(2):704-716. PubMed ID: 38318727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.
    Besag FMC; Vasey MJ; Chin RFM
    Expert Opin Pharmacother; 2023; 24(11):1249-1268. PubMed ID: 37212330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vagus nerve stimulation vs. corpus callosotomy in the treatment of Lennox-Gastaut syndrome: a meta-analysis.
    Lancman G; Virk M; Shao H; Mazumdar M; Greenfield JP; Weinstein S; Schwartz TH
    Seizure; 2013 Jan; 22(1):3-8. PubMed ID: 23068970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lennox-Gastaut syndrome: a comprehensive review.
    Asadi-Pooya AA
    Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying the ILAE diagnostic criteria for Lennox-Gastaut syndrome in the real-world setting: A multicenter retrospective cohort study.
    Nightscales R; Chen Z; Barnard S; Auvrez C; Tao G; Sivathamboo S; Bennett C; Rychkova M; D'Souza W; Berkovic SF; Nicolo JP; O'Brien TJ; Perucca P; Scheffer IE; Kwan P
    Epilepsia Open; 2024 Apr; 9(2):602-612. PubMed ID: 38135919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
    Sharawat IK; Panda PK; Panda P; Dawman L
    Seizure; 2021 Oct; 91():296-307. PubMed ID: 34273668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.